83 related articles for article (PubMed ID: 6320589)
1. Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.
Agnati LF; Fuxe K; Benfenati F; Battistini N
Acta Physiol Scand; 1983 Dec; 119(4):459-61. PubMed ID: 6320589
[No Abstract] [Full Text] [Related]
2. Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene.
von Euler G; Fuxe K; Benfenati F; Hansson T; Agnati LF; Gustafsson JA
Acta Physiol Scand; 1989 Apr; 135(4):443-8. PubMed ID: 2525310
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.
Agnati LF; Fuxe K; Battistini N; Giardino L; Benfenati F; Martire M; Ruggeri M
Acta Physiol Scand; 1985 May; 124(1):125-8. PubMed ID: 2990164
[No Abstract] [Full Text] [Related]
4. Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism.
von Euler G; van der Ploeg I; Fredholm BB; Fuxe K
J Neurochem; 1991 Jan; 56(1):178-83. PubMed ID: 1824779
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin.
Liu Y; Hillefors-Berglund M; von Euler G
Brain Res; 1994 Apr; 643(1-2):343-8. PubMed ID: 7913398
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain.
von Euler G; Meister B; Hökfelt T; Fuxe K
Acta Physiol Scand; 1989 Oct; 137(2):309-10. PubMed ID: 2618764
[No Abstract] [Full Text] [Related]
8. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
Agnati LF; Celani MF; Fuxe K
Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
[No Abstract] [Full Text] [Related]
9. Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes.
Li XM; Finnman UB; von Euler G; Hedlund PB; Fuxe K
Neurosci Lett; 1993 Jun; 155(2):121-4. PubMed ID: 8104321
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain.
von Euler G
Brain Res; 1991 Oct; 561(1):93-8. PubMed ID: 1839140
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
Dubois A; Scatton B
Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin reduces the affinity of D-2 dopamine receptors in rat striatal membranes.
Von Euler G; Fuxe K
Acta Physiol Scand; 1987 Dec; 131(4):625-6. PubMed ID: 3442244
[No Abstract] [Full Text] [Related]
13. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin reduces the affinity of dopamine D2 receptors in membranes from post mortem human caudate-putamen.
von Euler G; Mailleux P; Vanderhaeghen JJ; Fuxe K
Neurosci Lett; 1990 Feb; 109(3):325-30. PubMed ID: 2139501
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ
J Med Chem; 1990 Dec; 33(12):3122-4. PubMed ID: 2147956
[No Abstract] [Full Text] [Related]
16. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
[TBL] [Abstract][Full Text] [Related]
17. Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro.
Agnati LF; Fuxe K
Biosci Rep; 1983 Dec; 3(12):1101-5. PubMed ID: 6320923
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
19. Alcohol-preferring rats have fewer dopamine D2 receptors in the limbic system.
Stefanini E; Frau M; Garau MG; Garau B; Fadda F; Gessa GL
Alcohol Alcohol; 1992 Mar; 27(2):127-30. PubMed ID: 1355967
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic localization of dopamine receptors in the spinal cord of the rat using [3H]-N-propylnorapomorphine.
Scatton B; Dubois A; Cudennec A
J Neural Transm; 1984; 59(3):251-6. PubMed ID: 6736950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
